Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link?

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Molecular Neurobiology

• Publication date

  2019-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12035-019-1553-yPMID 30924075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversible Posterior Leukoencephalopathy Syndrome

  2020cited by this paper
• Recurrent reversible posterior encephalopathy syndrome with a response to nimodipine

  2019cited by this paper
• The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus

  2018cited by this paper
• Vasopressin, Central Autonomic Control and Blood Pressure Regulation

  2018cited by this paper
• Predictors of oedema type in reversible posterior leukoencephalopathy syndrome with preeclampsia or eclampsia.

  2018cited by this paper
• Association between 3'UTR polymorphisms in genes ACVR2A, AGTR1 and RGS2 and preeclampsia.

  2018cited by this paper
• Plasma copeptin as a predictor of kidney disease

  2018cited by this paper
• Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome

  2018cited by this paper
• Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia.

  2018cited by this paper
• Posterior reversible encephalopathy syndrome in eclampsia

  2018cited by this paper
• Acute intermittent porphyria presenting with seizures and posterior reversible encephalopathy syndrome

  2018cited by this paper
• Astroglial Modulation of Hydromineral Balance and Cerebral Edema

  2018cited by this paper
• Pharmacological management of hyponatremia

  2018cited by this paper
• Effects of alcohol and psychostimulants on the vasopressin system: Behavioural implications

  2018cited by this paper
• Posterior Reversible Leukoencephalopathy Syndrome After Kratom Ingestion

  2017cited by this paper
• Acute Intermittent Porphyria Presenting with Posterior Reversible Encephalopathy Syndrome, Accompanied by Prolonged Vasoconstriction

  2017cited by this paper
• Posterior reversible encephalopathy syndrome in children with kidney disease

  2017cited by this paper
• Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy

  2017cited by this paper
• Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?

  2017cited by this paper
• Severe Hyponatremia in a Single-Center Series of 84 Homogenously Treated Children With Acute Lymphoblastic Leukemia

  2017cited by this paper
• A Case of ALL Developing Posterior Reversible Encephalopathy Secondary to Hyponatremia.

  2017cited by this paper
• Central and peripheral roles of vasopressin in the circadian defense of body hydration.

  2017cited by this paper
• An atypical subacute presentation of posterior reversible encephalopathy syndrome

  2017cited by this paper
• Approaches Mediating Oxytocin Regulation of the Immune System

  2017cited by this paper
• Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

  2017cited by this paper
• Pathophysiology of copeptin in kidney disease and hypertension

  2017cited by this paper
• Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.

  2017cited by this paper
• Prognostic role of copeptin after traumatic brain injury: A systematic review and meta‐analysis of observational studies

  2017cited by this paper
• Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer

  2017cited by this paper
• Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

  2017cited by this paper
• Are cytokines and chemokines suitable biomarkers for Takayasu arteritis?

  2017cited by this paper
• Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury

  2017cited by this paper
• Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome

  2017cited by this paper
• Posterior reversible encephalopathy syndrome

  2017cited by this paper
• Posterior reversible encephalopathy in the intensive care unit.

  2017cited by this paper
• [Posterior Reversible Encephalopathy Syndrome Triggerred By Alcohol Withdrawal].

  2017cited by this paper
• G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.

  2016cited by this paper
• Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation

  2016cited by this paper
• Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials

  2016cited by this paper
• Assessment of Diagnostic and Prognostic Role of Copeptin in the Clinical Setting of Sepsis

  2016cited by this paper
• Electrolyte disorders associated with the use of anticancer drugs.

  2016cited by this paper
• EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.

  2016cited by this paper
• Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature

  2016cited by this paper
• Vasopressin Hypersecretion-Associated Brain Edema Formation in Ischemic Stroke: Underlying Mechanisms.

  2016cited by this paper
• Hyponatremia in cancer patients: Time for a new approach.

  2016cited by this paper
• Tyrosine kinase inhibitor-associated syndrome of inappropriate secretion of anti-diuretic hormone

  2016cited by this paper
• EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.

  2016cited by this paper
• A Commonly Missed Well Known Entity- Acute Intermittent Porphyria: A Case Report.

  2016cited by this paper
• Regulation of Neuronal Activity in Hypothalamic Vasopressin Neurons.

  2015cited by this paper
• Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis

  2015cited by this paper
• Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels

  2015cited by this paper
• Serum Lactate Dehydrogenase as a Predictor of Outcome in Posterior Reversible Encephalopathy Syndrome: Imperative to Unify

  2015cited by this paper
• A case of posterior reversible encephalopathy syndrome associated with acute pancreatitis and chronic alcoholism.

  2015cited by this paper
• Vasopressin: the missing link for preeclampsia?

  2015cited by this paper
• Novel A219P Mutation of Hydroxymethylbilane Synthase Identified in a Chinese Woman with Acute Intermittent Porphyria and Syndrome of Inappropriate Antidiuretic Hormone

  2015cited by this paper
• Reversible posterior leukoencephalopathy syndrome after withdrawal of antipsychotic medication in the context of lithium intoxication.

  2015cited by this paper
• Venlafaxine as single therapy associated with hypertensive encephalopathy

  2015cited by this paper
• Renal Artery Stenosis Precipitates Hyponatremic Hypertensive Syndrome and Posterior Reversible Leukoencephalopathy

  2015cited by this paper
• Copeptin: Pathophysiology and potential clinical impact.

  2015cited by this paper
• Lithium Toxicity and PRES: A Novel Association

  2015cited by this paper
• Molecular pathophysiology of cerebral edema

  2015cited by this paper
• Posterior Reversible Encephalopathy Syndrome in End-Stage Kidney Disease: Not Strictly Posterior or Reversible

  2015cited by this paper
• Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations.

  2014cited by this paper
• Role of vasopressin and its antagonism in stroke related edema

  2014cited by this paper
• Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review

  2014cited by this paper
• Posterior Reversible Encephalopathy Syndrome Due to Hyponatremia

  2014cited by this paper
• Copeptin as a diagnostic biomarker for sepsis-related deaths.

  2014cited by this paper
• Effect of corticosteroids on arginine vasopressin after pediatric cardiac surgery.

  2014cited by this paper
• Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors

  2013cited by this paper
• Acute alcohol withdrawal accompanied by posterior reversible encephalopathy syndrome

  2013cited by this paper
• Evidence for involvement of central vasopressin V1b and V2 receptors in stress‐induced baroreflex desensitization

  2013cited by this paper
• Role of vaptans in the management of hyponatremia.

  2013cited by this paper
• A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer

  2013cited by this paper
• [Development of syndrome of inappropriate secretion of ADH and reversible posterior leukoencephalopathy during initial rituximab-CHOP therapy in a patient with diffuse large B-cell lymphoma].

  2013cited by this paper
• Posterior reversible encephalopathy syndrome with documented hyponatraemia

  2013cited by this paper
• Severe neurological symptoms in a patient with advanced renal cell carcinoma treated with sunitinib

  2013cited by this paper
• Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone

  2013cited by this paper
• [Recurrent reversible posterior encephalopathy syndrome with a response to nimodipine].

  2012cited by this paper
• Vasopressin V1a and V1b receptors: from molecules to physiological systems.

  2012cited by this paper
• Posterior reversible encephalopathy syndrome postautologous peripheral stem cell transplantation for multiple myeloma

  2012cited by this paper
• Desmopressin-induced posterior reversible encephalopathy syndrome.

  2012cited by this paper
• Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.

  2012cited by this paper
• Inhibitory Effect of Dexamethasone on Arginine-Vasopressin Release Induced by Physical Exercise in Man

  2011cited by this paper
• Posterior reversible encephalopathy syndrome induced by anti-VEGF agents

  2011cited by this paper
• Posterior reversible encephalopathy syndrome following disulfiram intoxication

  2011cited by this paper
• V2 Receptor–Mediated Autocrine Role of Somatodendritic Release of AVP in Rat Vasopressin Neurons Under Hypo-Osmotic Conditions

  2011cited by this paper
• Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor

  2011cited by this paper
• Posterior reversible encephalopathy syndrome in chronic alcoholism with acute psychiatric symptoms.

  2010cited by this paper
• Apparent diffusion coefficient map based on diffusion-weighted magnetic resonance imaging is useful in diagnosing the brainstem variant of reversible posterior leukoencephalopathy syndrome with uremia

  2010cited by this paper
• Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

  2010cited by this paper
• Hyponatremia and Inflammation: The Emerging Role of Interleukin-6 in Osmoregulation

  2010cited by this paper
• Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats.

  2009cited by this paper
• The vasopressin and copeptin response to infection, severe sepsis, and septic shock*

  2009cited by this paper
• Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

  2009cited by this paper
• Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema

  2008cited by this paper
• Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Imatinib

  2008cited by this paper
• Intrahypothalamic angiogenesis induced by osmotic stimuli correlates with local hypoxia: a potential role of confined vasoconstriction induced by dendritic secretion of vasopressin.

  2008cited by this paper
• Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation

  2008cited by this paper
• Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

  2008cited by this paper
• The syndrome of inappropriate antidiuresis.

  2007cited by this paper

• A Case Report of Posterior Reversible Encephalopathy Syndrome With Intracranial Hemorrhage After Split-Liver Transplantation.

  2026cites this paper
• A (PRES)sing Matter: Two Cases of Posterior Reversible Encephalopathy Syndrome (PRES) in Pregnancy and Postpartum

  2025cites this paper
• Association of Post-streptococcal Glomerulonephritis and Paediatric Posterior Reversible Encephalopathy Syndrome (PRES): A Case Report

  2025cites this paper
• Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy

  2024cites this paper
• Pathogenesis of acute encephalopathy in acute hepatic porphyria

  2023cites this paper
• The kidney–brain pathogenic axis in severe falciparum malaria

  2023cites this paper
• The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review

  2023cites this paper
• Reversible cerebral vasoconstriction syndrome: Considerable differential diagnosis

  2023cites this paper
• Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets

  2023influential citation
• Neuro-Ophthalmic Visual Impairment in the Setting of COVID-19

  2023cites this paper
• Posterior Reversible Encephalopathy Syndrome after Pazopanib Therapy

  2023cites this paper
• Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report

  2022cites this paper
• Posterior Reversible Encephalopathy Syndrome: A Review of the Literature

  2021cites this paper
• Posterior Reversible Encephalopathy Syndrome

  2021cites this paper
• Posterior Reversible Encephalopathy Syndrome (PRES): Holohemispheric Watershed Pattern

  2021cites this paper
• Liquorpleozytose beim posterioren reversiblen Enzephalopathiesyndrom

  2021cites this paper
• Coexisting posterior reversible encephalopathy syndrome and ischemic hepatopathy: A case report

  2021cites this paper
• Atypical Posterior Reversible Encephalopathy Syndrome in a Postpartum Woman With Moyamoya Disease: A Case Report and Literature Review

  2021cites this paper
• Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome

  2021cites this paper
• Editorial: Posterior Reversible Encephalopathy Syndrome and Associated Diseases

  2020cites this paper
• Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome

  2020cites this paper
• Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis

  2020cites this paper
• Posterior reversible encephalopathy syndrome in preeclampsia and eclampsia: The role of hypomagnesemia

  2020cites this paper
• Posterior reversible encephalopathy syndrome in an oncological normotensive patient: evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment

  2020cites this paper
• Uþpakalinës gráþtamosios encefalopatijos sindromas: klinikinio atvejo pristatymas ir literatûros apþvalga

  2020influential citation
• Etiologies, Cerebral Vasomotion, and Endothelial Dysfunction in the Pathophysiology of Posterior Reversible Encephalopathy Syndrome in Pediatric Patients

  2020cites this paper
• Heritable and non-heritable uncommon causes of stroke

  2020cites this paper
• Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome

  2020cites this paper
• Posterior Reversible Encephalopathy Syndrome in Clinical Toxicology: A Systematic Review of Published Case Reports

  2020cites this paper
• Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy

  2020cites this paper
• Posterior Reversible Encephalopathy Syndrome, Multiple Sclerosis and interferon therapy: Association, co-incidence or convoluted interplay?

  2020cites this paper
• Pazopanib-induced posterior reversible encephalopathy syndrome with possible syndrome of inappropriate secretion of antidiuretic hormone: an incidental or pathophysiological association?

  2019cites this paper
• Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction.

  2019cites this paper
• Imaging of Atypical and Complicated Posterior Reversible Encephalopathy Syndrome

  2019cites this paper
• Posterior reversible encephalopathy syndrome in eclampsia

  2018cites this paper
• Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome

  2018cites this paper